Concepedia

Albumin levels as a biomarker for second Intravenous Immunoglobulin (IVIG) treatment in Guillain-Barre syndrome (GBS)

Anna Shalman, Shiri Savir, Yana Mechnik Steen, Andrey Ovanyan, Nancy Boniel, Leonid Koyfman, Yoav Bichovsky, Alexander Zlotnik, Moti Klein, Evgeni Brotfain

Journal of Clinical Neuroscience · 2020 · 10 citations · 9 references

DOI

Concepts

References

9

A clinical prognostic scoring system for Guillain-Barré syndrome

Rinske van Koningsveld, Ewout W. Steyerberg, Richard AC Hughes et al. · The Lancet Neurology · 2007 · 377 citations

, , +13

Early recognition of poor prognosis in Guillain-Barré syndrome

Christa Walgaard, Hester F. Lingsma, Liselotte Ruts et al. · Neurology · 2011 · 329 citations · Full text

, , +14

Association of Albumin Levels With Outcome in Intravenous Immunoglobulin–Treated Guillain-Barré Syndrome

Willem‐Jan R. Fokkink, Christa Walgaard, Krista Kuitwaard et al. · JAMA Neurology · 2016 · 63 citations

, , +12

Hypoalbuminemia is a Marker of Overhydration in Chronic Maintenance Patients on Dialysis

Francis Dumler · ASAIO Journal · 2003 · 47 citations

, , +16

Second IVIg course in Guillain‐Barré syndrome patients with poor prognosis (SID‐GBS trial): Protocol for a double‐blind randomized, placebo‐controlled clinical trial

Christa Walgaard, Bart C. Jacobs, Hester F. Lingsma et al. · Journal of the Peripheral Nervous System · 2018 · 46 citations · Full text

, , +11